- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
InterMune Inc+ Add to Watchlist
ITMN:US13.3300 USD 0.6400 4.58%
As of 17:20:00 ET on 12/11/2013.
Company Profile for InterMune Inc (ITMN)
InterMune, Inc. is a biotechnology company. The Company's focus is on the research, development and commercialization of therapies in pulmonology and fibrotic diseases. InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor pulmonary and fibrotic diseases.
Key Executives for InterMune Inc (ITMN)
|Daniel G Welch "Dan"Chairman/President/CEO||John HodgmanExec VP:Finance & Admin/CFO|
|Giacomo Di NepiExec VP/Mng Dir:Europe||Andrew K W PowellExec VP/Secretary/General Counsel|
|Robin J SteeleSenior VP/Secretary/Gen Cnsl||Jonathan A LeffExec VP:Research & Development|